Flunarizine for Migraine Prophylaxis in Children
Flunarizine is an effective second-line medication for migraine prophylaxis in children and can be safely used in pediatric populations. 1, 2
Efficacy and Positioning in Treatment Algorithm
- Flunarizine (10 mg/day) is considered a second-line medication for migraine prophylaxis after first-line options (beta blockers, topiramate, and candesartan) have been tried 1
- Clinical trials demonstrate that flunarizine significantly reduces both the frequency and average duration of headache attacks in children 3
- In comparative studies, flunarizine has shown effectiveness comparable to other prophylactic medications used in pediatric migraine, including propranolol, topiramate, and cyproheptadine 2
Dosing in Children
- For children, the recommended starting dose is 5 mg daily 4, 3
- The dose may be increased to 10 mg daily if there is inadequate response after 2-4 weeks of treatment 4
- Clinical improvement is typically observed between 2-4 weeks after initiating treatment 4
Evidence of Effectiveness
- Double-blind, placebo-controlled studies have shown that flunarizine (5 mg/day) significantly reduces both frequency and duration of migraine attacks in children 3
- A systematic review with meta-analysis confirmed that flunarizine is effective for episodic migraine prophylaxis, supporting guideline recommendations 5
- A recent study (2022) demonstrated that flunarizine significantly reduced Pediatric Migraine Disability Assessment Scores (PedMIDAS) in children with migraine 2
Side Effects and Monitoring
- The most common side effects of flunarizine in children include:
- Less common but important side effects to monitor:
When to Consider Prophylaxis
- Migraine prophylaxis should be considered in children when:
- Symptoms cause frequent school absenteeism 2
- Quality of life is significantly impaired 2
- There are recurring emergency room visits 2
- Frequent analgesic use raises concerns about medication overuse headache 2
- Patients are adversely affected by migraine on ≥2 days per month despite optimized acute treatment 1
Treatment Algorithm for Pediatric Migraine Prophylaxis
Start with first-line agents:
If first-line agents fail or are contraindicated, consider second-line options:
For children under 6 years:
Practical Considerations
- Treatment duration should typically be at least 3-6 months before evaluating full efficacy 3
- Regular follow-up is essential to monitor for side effects and assess treatment response 2
- Consider discontinuing treatment after a period of stability to determine if prophylaxis is still needed 1
- Avoid medication overuse of acute treatments during prophylactic therapy 1